Why Pharmaceutical Companies Are Targeting the US$ 8.84 Billion Bile Duct Cancer Market
The Bile Duct Cancer Market is evolving as healthcare providers increasingly focus on early diagnosis, advanced treatment options, and improved patient outcomes for cholangiocarcinoma. Bile duct cancer develops in the bile ducts, which carry bile from the liver and gallbladder to the small intestine. Treatment approaches include surgery, chemotherapy, targeted therapy, immunotherapy, radiation...
0 Comentários 0 Compartilhamentos 112 Visualizações 0 Anterior